Medication info
Mepril M Tablet 2/500mg (Glimepiride, Metformin Hydrochloride)

Mepril M Tablet 2/500mg (Glimepiride, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletGlimepiride›2mg / 1 tablet
Manufacturer / importer
IYON Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201902053 · Approved 2019.04.04 · Insurance code 658603690

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered immediately before or with a meal, 1~2 times daily. The dose may be adjusted in consideration of each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Usually, treatment is initiated at a low dose, and the dose may be adjusted according to the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and based on blood glucose monitoring results, it was gradually increased up to glimepiride/metformin hydrochloride 8mg/2000mg. For glimepiride as a single agent, there is generally little additional effect at doses greater than 4mg per day, but some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as an alternative to combination therapy, administer according to the dosage and administration of the glimepiride and metformin hydrochloride currently being taken concomitantly. Even if a previous dose was missed, do not take more than one dose at the next administration.

Ingredients

Manufacturer
IYON Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used in combination with Glimepiride and Metformin to improve blood sugar control in patients with type 2 diabetes. It is more effective when used alongside dietary changes and exercise, helping to stabilize blood sugar levels. This positively impacts diabetes treatment and improves health.

How to take

Adult dose

This medicine is administered immediately before or with a meal, 1~2 times daily. The dose may be adjusted in consideration of each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Usually, treatment is initiated at a low dose, and the dose may be adjusted according to the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and based on blood glucose monitoring results, it was gradually increased up to glimepiride/metformin hydrochloride 8mg/2000mg. For glimepiride as a single agent, there is generally little additional effect at doses greater than 4mg per day, but some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as an alternative to combination therapy, administer according to the dosage and administration of the glimepiride and metformin hydrochloride currently being taken concomitantly. Even if a previous dose was missed, do not take more than one dose at the next administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia; therefore, it should be discontinued if there is acute decline in kidney function. If symptoms of dehydration occur, it is advisable to temporarily stop this medication and consult a physician. Caution is necessary when used with certain medications that may affect kidney function, and excessive alcohol consumption should be avoided. Patients with insulin-dependent diabetes, acute metabolic acidosis, severe hepatic or renal dysfunction should not use this medication. It is safe for pregnant or breastfeeding women to avoid using this medication. During the initial stages of treatment, the risk of hypoglycemia is high, so regular meal intake and careful monitoring of hypoglycemic symptoms are necessary. Gastrointestinal disturbances may occur while taking this medication; if symptoms are severe, consult a physician. If allergic reactions occur, notify medical personnel immediately. Rarely, blood abnormalities or liver function abnormalities may occur, so regular examinations are necessary. This medication may decrease vitamin B12 levels, so regular blood tests are recommended with long-term use. Overdosage may lead to hypoglycemia or lactic acidosis; therefore, strict adherence to the dosage is essential, and immediate medical attention is required if any abnormal symptoms occur. Regular checks of blood sugar control are necessary, and inform your healthcare provider of all medications being taken due to potential interactions. Extra caution is needed when driving or operating machinery due to the risk of hypoglycemia or dizziness. Children and elderly individuals may require dosage adjustments and close monitoring of kidney function, with regular kidney examinations especially recommended for the elderly. This medication has not been sufficiently proven safe and effective for children, so caution is advised in its use.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distention, loss of appetite, dyspepsia, constipation, abdominal pain, metallic taste, vision impairment, taste disorder, erythema, itching, hives, thrombocytopenia, leukopenia, hemolytic anemia, anemia, agranulocytosis, pancytopenia, peripheral neuropathy, increased liver enzymes, liver function damage, bile secretion disorder, jaundice, hepatitis, allergic vasculitis, photodermatosis, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency, encephalopathy, hair loss, weight gain, headache, severe hunger, fatigue, sleepiness, weakness, drowsiness, sleep disorder, instability, aggression, attention deficit, inability to concentrate, abnormal reactions, depression, confusion, language disorder, aphasia, tremor, paralysis, sensory disorder, dizziness, inability to self-regulate, delirium, cerebral convulsions, loss of consciousness, coma, weak breathing, slow heart rate, sweating, clammy skin, anxiety, rapid heart rate, hypertension, palpitations, angina, deep vein thrombosis, dizziness, liver dysfunction, prostate enlargement, palpitations, dizziness, leg edema, cardiac arrest, rectal cancer, arthralgia, facial edema, erectile dysfunction, facial flushing, gastritis, hematological abnormalities, pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. It is advisable to keep the storage temperature between 1 to 30 degrees Celsius. Storing it this way can prolong the medication's effectiveness.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.